Icon (ICLR) Short-term Investments (2009 - 2025)
Icon's (ICLR) quarterly Short-term Investments came in at $82.0 million in Q4 2025, up 41.59% year-over-year from $57.9 million in Q4 2024, and up 41.59% quarter-over-quarter from $57.9 million in Q4 2024.
Analysis
Icon (ICLR) Short-term Investments (2009 - 2025) Analysis & Trends
Icon (ICLR) has reported Short-term Investments for 17 consecutive years, with $82.0 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Short-term Investments rose 41.59% year-over-year to $82.0 million in Q4 2025; TTM through Dec 2025 was $82.0 million, a 41.59% increase from a year earlier, with the FY2025 full-year figure at $82.0 million, up 41.59% from the prior year.
- Short-term Investments was $82.0 million for Q4 2025 at Icon, up from $57.9 million in the prior quarter.
- Over five years, Short-term Investments peaked at $82.0 million in Q4 2025 and troughed at $1.7 million in Q1 2023.
- A 5-year average of $14.3 million and a median of $1.7 million in 2021 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments tumbled 94.01% in 2023 and surged 2865.61% in 2024, its largest moves.
- Over 5 years, Short-term Investments stood at $22.6 million in 2021, then jumped by 44.44% to $32.6 million in 2022, then plunged by 94.01% to $2.0 million in 2023, then surged by 2865.61% to $57.9 million in 2024, then surged by 41.59% to $82.0 million in 2025.
- The last three Short-term Investments figures came in at $82.0 million (Q4 2025), $57.9 million (Q4 2024), and $2.0 million (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 82.05 Mn |
| Dec 31, 2024 | 57.95 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 32.63 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 22.59 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.73 Mn |
| Mar 31, 2021 | 1.73 Mn |
| Dec 31, 2020 | 15.77 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | 1.73 Mn |
| Mar 31, 2020 | 1.73 Mn |
| Dec 31, 2019 | 10.05 Mn |